MRK vs MRVL: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and Marvell Technology, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
VS
Marvell Technology, Inc. · Technology
$310.58
-18.5% upside to fair value
Grade D
QuantHub Verdict
MRK has more upside to fair value
(-12.1%).
MRK trades at a lower forward P/E
(32.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
MRVL |
| Current Price |
$113.87 |
$310.58 |
| Fair Value Estimate |
$100.14 |
$253.23 |
| Upside to Fair Value |
-12.1%
|
-18.5%
|
| Market Cap |
$281.2B |
$271.7B |
| Forward P/E |
32.0x
|
105.7x
|
| EV / EBITDA |
17.3x
|
59.1x
|
| Price / Sales |
4.3x
|
31.2x
|
| Price / FCF |
19.9x
|
163.2x
|
| Revenue Growth YoY |
+4.3%
|
+27.6%
|
| Gross Margin |
75.9%
|
50.6%
|
| Operating Margin |
27.6%
|
16.2%
|
| Return on Equity |
17.9%
|
16.8%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
5.02%
|
0.61%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Marvell Technology, Inc. designs and supplies semiconductor solutions primarily focused on data infrastructure markets including cloud, AI, carrier 5G, and custom silicon. The company benefits from a narrow but widening moat driven by strong IP and hyperscaler relationships, led by an experienced CEO with a track record of transformational M&A. Despite strong revenue growth of 42% year-over-year …
Accumulation Zones
| Metric |
MRK |
MRVL |
| Zone Low |
$75.11 |
$189.92 |
| Zone High |
$85.12 |
$215.25 |
| In Buy Zone? |
No
|
No
|